|
|
|
|
LEADER |
01000caa a22002652 4500 |
001 |
NLM170968448 |
003 |
DE-627 |
005 |
20250208100011.0 |
007 |
tu |
008 |
231223s2007 xx ||||| 00| ||chi c |
028 |
5 |
2 |
|a pubmed25n0570.xml
|
035 |
|
|
|a (DE-627)NLM170968448
|
035 |
|
|
|a (NLM)17577437
|
040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rakwb
|
041 |
|
|
|a chi
|
100 |
1 |
|
|a Ke, Shao-fa
|e verfasserin
|4 aut
|
245 |
1 |
0 |
|a Study on expression of matrix metalloproteinase-2 and matrix metalloproteinase-9 in brain tissue adjacent to hemorrhage after brain hemorrhage in human
|
264 |
|
1 |
|c 2007
|
336 |
|
|
|a Text
|b txt
|2 rdacontent
|
337 |
|
|
|a ohne Hilfsmittel zu benutzen
|b n
|2 rdamedia
|
338 |
|
|
|a Band
|b nc
|2 rdacarrier
|
500 |
|
|
|a Date Completed 09.07.2009
|
500 |
|
|
|a Date Revised 19.06.2007
|
500 |
|
|
|a published: Print
|
500 |
|
|
|a Citation Status MEDLINE
|
520 |
|
|
|a OBJECTIVE: To investigate the expression and significance of matrix metalloproteinase-2 (MMP-2) and MMP-9 in peri-hematoma brain tissues after acute brain hemorrhage in human
|
520 |
|
|
|a METHODS: Forty-two patients with acute brain hemorrhage received surgery, the brain tissues adjacent to hemorrhagic site were obtained during surgery, and positive expressions of MMP-2 and MMP-9 were determined with immunohistochemical staining. Brain tissues from 30 patients with cerebral trauma were obtained to serve as controls
|
520 |
|
|
|a RESULTS: The positive expressions of MMP-2 and MMP-9 in focal brain tissues were significantly elevated in early acute brain hemorrhage. Compared with 28 and 27 cases with MMP-2 and MMP-9 positive expression respectively in control group, there were 39 and 37 cases with MMP-2 and MMP-9 positive expression respectively in acute brain hemorrhage group. There were no significant differences between two groups (both P>0.05)
|
520 |
|
|
|a CONCLUSION: MMP-2 and MMP-9 might contribute to brain edema formation in the acute intra-cerebral hemorrhage of human
|
650 |
|
4 |
|a English Abstract
|
650 |
|
4 |
|a Journal Article
|
650 |
|
4 |
|a Research Support, Non-U.S. Gov't
|
650 |
|
7 |
|a MMP2 protein, human
|2 NLM
|
650 |
|
7 |
|a EC 3.4.24.24
|2 NLM
|
650 |
|
7 |
|a Matrix Metalloproteinase 2
|2 NLM
|
650 |
|
7 |
|a EC 3.4.24.24
|2 NLM
|
650 |
|
7 |
|a Matrix Metalloproteinase 9
|2 NLM
|
650 |
|
7 |
|a EC 3.4.24.35
|2 NLM
|
700 |
1 |
|
|a Jin, Xiao-ping
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Zhang, Ke-hao
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Wang, Jun-xing
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Hu, Xiao-ming
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Zhang, Dan-hong
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Chen, Qiu-yue
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Zhou, Yuan-lin
|e verfasserin
|4 aut
|
773 |
0 |
8 |
|i Enthalten in
|t Zhongguo wei zhong bing ji jiu yi xue = Chinese critical care medicine = Zhongguo weizhongbing jijiuyixue
|d 1998
|g 19(2007), 6 vom: 18. Juni, Seite 336-9
|w (DE-627)NLM098227793
|x 1003-0603
|7 nnns
|
773 |
1 |
8 |
|g volume:19
|g year:2007
|g number:6
|g day:18
|g month:06
|g pages:336-9
|
912 |
|
|
|a GBV_USEFLAG_A
|
912 |
|
|
|a SYSFLAG_A
|
912 |
|
|
|a GBV_NLM
|
912 |
|
|
|a GBV_ILN_350
|
951 |
|
|
|a AR
|
952 |
|
|
|d 19
|j 2007
|e 6
|b 18
|c 06
|h 336-9
|